Andres Maldonado
Stock Analyst at HC Wainwright & Co.
(4.39)
# 488
Out of 4,413 analysts
35
Total ratings
48.57%
Success rate
30%
Average return
Main Sectors:
Top Industries:
6 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DAWN Day One Biopharmaceuticals | Reiterates: Buy | $50 | $17.69 | +182.65% | 7 | Apr 24, 2024 | |
| CGON CG Oncology | Reiterates: Buy | $75 | $40.62 | +84.64% | 2 | Apr 4, 2024 | |
| ERAS Erasca | Reiterates: Buy | $8 | $2.09 | +282.78% | 3 | Mar 28, 2024 | |
| SRRK Scholar Rock Holding | Reiterates: Buy | $30 | $14.96 | +100.53% | 6 | Mar 19, 2024 | |
| IKNA Ikena Oncology | Reiterates: Buy | $11 | $1.30 | +746.15% | 8 | Mar 19, 2024 | |
| HOWL Werewolf Therapeutics | Maintains: Buy | $15 | $6.02 | +149.17% | 9 | Mar 7, 2024 |
Day One Biopharmaceuticals
Apr 24, 2024
Reiterates: Buy
Price Target: $50
Current: $17.69
Upside: +182.65%
CG Oncology
Apr 4, 2024
Reiterates: Buy
Price Target: $75
Current: $40.62
Upside: +84.64%
Erasca
Mar 28, 2024
Reiterates: Buy
Price Target: $8
Current: $2.09
Upside: +282.78%
Scholar Rock Holding
Mar 19, 2024
Reiterates: Buy
Price Target: $30
Current: $14.96
Upside: +100.53%
Ikena Oncology
Mar 19, 2024
Reiterates: Buy
Price Target: $11
Current: $1.30
Upside: +746.15%
Werewolf Therapeutics
Mar 7, 2024
Maintains: Buy
Price Target: $15
Current: $6.02
Upside: +149.17%